Behavioral and neuroendocrine responses to m-chlorophenylpiperazine in subtypes of alcoholics and in healthy comparison subjects

American Journal of Psychiatry

Volumn 154, Issue 1, 1997, Pages 81-87

  George, David T ^a   Benkelfat, Chawki ^b   Rawlings, Robert R ^b   Eckardt, Michael J ^b   Phillips, Monte J ^b   Nutt, David J ^b   Wynne, Debra ^b   Murphy, Dennis L ^b   Linnoila, Markku ^b  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; ALCOHOL; SEROTONIN; SEROTONIN RECEPTOR;

ADULT; ALCOHOL ABUSE; ALCOHOLISM; ANGER; ANTISOCIAL BEHAVIOR; ANXIETY NEUROSIS; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRINKING BEHAVIOR; EUPHORIA; HUMAN; HUMAN EXPERIMENT; MALE; OBSESSION; PANIC; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RATING SCALE; SCHIZOPHRENIA; SEROTONIN BLOOD LEVEL; SEROTONINERGIC SYSTEM;

EID: 0031015242     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.154.1.81     Document Type: Article

References (52)

1. George DT, Nutt DJ, Rawlings RR, Phillips MJ, Eckardt MJ, Potter WZ, Linnoila M: Behavioral and endocrine responses to clomipramine in panic disorder patients with or without alcoholism. Biol Psychiatry 1995; 37:112-119
2. Ballenger JC, Goodwin FK, Major LF, Brown GL: Alcohol and central serotonin metabolism in man. Arch Gen Psychiatry 1979; 36:224-227
3. Buydens-Branchey L, Branchey MH, Noumair D, Lieber CS: Age of alcoholism onset, II: relationship to susceptibility to serotonin precursor availability. Arch Gen Psychiatry 1989; 46:231-236
4. Melchior CL, Myers RD: Genetic differences in ethanol drinking of the rat following injection of 6-OHDA, 5,6-DHT or 5,7-DHT into the cerebral ventricles. Pharmacol Biochem Behav 1976; 5:63-72
5. Murphy JM, McBride WJ, Lumeng L, Li T-K: Contents of monoamines in forebrain regions of alcohol-preferring (P) and non-preferring (NP) lines of rats. Pharmacol Biochem Behav 1987; 26:389-392
6. Myers RD, Evans JE, Yaksh TL: Ethanol preference in the rat: interactions between brain serotonin and ethanol, acetaldehyde, paraldehyde, 5-HTP and 5-HTOL. Neuropharmacology 1972; 11:539-549
7. Wong DT, Threlkeld PG, Lumeng L, Li T-K: Higher density of serotonin-lA receptors in the hippocampus and cerebral cortex of alcohol-preferring P rats. Life Sci 1990; 46:231-235
8. von Knorring A-L, Bohman M, von Knorring L, Oreland L: Platelet MAO activity as a biological marker in subgroups of alcoholism. Acta Psychiatr Scand 1985; 72:51-58
9. Bohman M: Some genetic aspects of alcoholism and criminality. Arch Gen Psychiatry 1978; 35:269-276
10. Cloninger CR, Bohman M, Sigvardsson S: Inheritance of alcohol abuse: cross-fostering analysis of adopted men. Arch Gen Psychiatry 1981; 38:861-868
11. Bohman M, Cloninger R, Sigvardsson S, von Knorring AL: The genetics of alcoholism and related disorders. J Psychiatr Res 1987; 21:447-452
12. Cloninger CR: Neurogenetic adaptive mechanisms in alcoholism. Science 1987; 236:410-416
13. Signs SA, Schechter MD: The role of dopamine and serotonin receptors in the mediation of the ethanol interoceptive cue. Pharmacol Biochem Behav 1988; 30:55-64
14. Schechter MD: Stimulus properties of ethanol and depressant drugs, in Drug Discrimination and State Dependent Learning. Edited by Ho BT, Richards DW, Chute DL. London, Academic Press, 1978, pp 103-117
15. Kahn RS, Wetzler S: m-Chlorophenylpiperazine as a probe of serotonin function. Biol Psychiatry 1991; 30:1139-1166
16. Murphy DL, Lesch KP, Aulakh CS, Pigott TA: Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans. Pharmacol Rev 1991; 43:527-552
17. Quattrone A, Schettini G, Annunziato L, DiRenzo G: Pharmacological evidence of supersensitivity of central serotonergic receptors involved in control of prolactin secretion. Eur J Pharmacol 1981; 76:9-13
18. Endicott J, Spitzer RL: A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978; 35:837-844
19. Selzer M: The Michigan Alcoholism Screening Test: the quest for a new diagnostic instrument. Am J Psychiatry 1971; 127:1653-1658
20. Spitzer RL, Endicott J, Robins E: Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders, 3rd ed, updated. New York, New York State Psychiatric Institute, Biometrics Research, 1981
21. Charney DS, Woods SW, Goodman WK, Heninger GR: Serotonin function in anxiety, II: effects of the serotonin agonist m-CPP in panic disorder patients and healthy subjects. Psychopharmacology (Berl) 1987; 92:14-24
22. Murphy DL, Mueller EA, Hill JL, Tolliver TJ, Jacobsen FM: Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers, Psychopharmacology (Berl) 1989; 98:275-282
23. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
24. Spielberger CD, Gorsuch RL, Lushene RD: STAI Manual. Palo Alto, Calif, Consulting Psychologists Press, 1970
25. Dixon WJ (ed): BMDP Statistical Software Manual. Berkeley, University of California Press, 1990
26. Benkelfat C, Murphy DL, Hill JL, George DT, Nutt D, Linnoila M: Ethanollike properties of the serotonergic partial agonist m-chlorophenylpiperazine in chronic alcoholic patients (letter). Arch Gen Psychiatry 1991; 48:383
27. Krystal JH, Webb E, Cooney N, Kranzler HR, Charney DS: Specificity of ethanollike effects elicited by serotonergic and nor-adrenergic mechanisms. Arch Gen Psychiatry 1994; 51:898-911
28. Buydens-Branchey L, Branchey MH, Noumair D: Age of alcoholism onset, I: relationship to psychopathology. Arch Gen Psychiatry 1989; 46:225-230
29. Babor TF, Hofmann M, Delboca FK, Hesselbrock V, Meyer RE, Dolinsky ZS, Rounsaville B: Types of alcoholics, I: evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch Gen Psychiatry 1992; 49:599-608
30. Irwin M, Schuckit M, Smith TL: Clinical importance of age at onset in type 1 and 2 primary alcoholics. Arch Gen Psychiatry 1990; 47:320-324
31. Humphrey PPA, Hartig P, Hoyer D: A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci 1993; 14:233-236
32. Hoyer D: Functional correlates of serotonin 5-HT1 recognition sites. J Recept Res 1988; 8:59-81
33. Hoyer D: 5-Hydroxytryptamine receptors and effector coupling mechanisms in peripheral tissues, in The Peripheral Actions of 5-Hydroxytryptamine. Edited by Fozard JR. New York, Oxford University Press, 1989, pp 72-99
34. Hoyer D, Schoeffter P: 5-HT receptors: subtypes and second messengers. J Recept Res 1991; 11:197-214
35. Sleight AJ, Carolo C, Petit N, Zwingelstein C, Bourson A: Identification of 5-hydroxytryptamine? receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment. Mol Pharmacol 1995; 47:99-103
36. Monsma FJ Jr, Shen Y, Ward RP, Hamblin MW, Sibley DR: Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol 1993; 43:320-327
37. Hamik A, Peroutka SJ: l-(m-Chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain. Biol Psychiatry 1989; 25:569-575
38. Conn PJ, Sanders-Bush E: Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5HT-1c) receptors. J Pharmacol Exp Ther 1987; 242:552-557
39. Robertson DW, Bloomquist W, Wong DT, Cohen ML: MCPP but not TFMPP is an antagonist at cardiac 5HT3 receptors. Life Sci 1992; 50:599-605
40. Kennett GA, Whitton P, Shah K, Curzon G: Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5HT1c receptor antagonists. Eur J Pharmacol 1989; 164:445-454
41. Kennett GA: 5-HT1c receptor antagonists have anxiolytic-like actions in the rat social interaction model. Psychopharmacology (Berl) 1992; 107:379-384
42. Seibyl JP, Krystal JH, Price LH, Woods SW, D'Amico C, Heninger GR, Charney DS: Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects. Psychiatry Res 1991; 38:227-236
43. Pigott TA, Zohar J, Hill JL, Bernstein SE, Grover GN, Zohar-Kadouch RC, Murphy DL: Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder. Biol Psychiatry 1991; 29:418-426
44. Pigott TA, Hill JL, Grady TA, L'Heureux F, Bernstein S, Rubenstein CS, Murphy DL: A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effects of metergoline prior to IV mCPP. Biol Psychiatry 1993; 33:3-14
45. Lee MA, Meltzer HY: Neuroendocrine responses to serotonergic agents in alcoholics. Biol Psychiatry 1991; 30:1017-1030
46. Kahn RS, Wetzler S, Asnis GM, Kling MA, Suckow RF, van Praag HM: Effects of m-chlorophenylpiperazine in normal subjects: a dose-response study. Psychopharmacology (Berl) 1990; 100:339-344
47. Adinoff B, Martin PR, Bone GHA, Eckardt MJ, Roehrich L, George DT, Moss HB, Eskay R, Linnoila M, Gold PW: Hypothalamic-pituitary-adrenal axis functioning and cerebrospinal fluid corticotropin releasing hormone and corticotropin levels in alcoholics after recent and long-term abstinence. Arch Gen Psychiatry 1990; 47:325-330
48. Berman JD, Cook DM, Buchman M, Keith LD: Diminished adrenocorticotropin response to insulin-induced hypoglycemia in nondepressed, actively drinking male alcoholics. J Clin Endocrinol Metab 1990; 71:712-717
49. George DT, Lindquist T, Alim T, Flood M, Eckardt MJ, Linnoila M: Abstinent alcoholics exhibit an exaggerated stress response to 2-deoxy-D-glucose (2DG) challenge. Alcohol Clin Exp Res 1994; 18:685-691
50. Lukas SE, Mendelson JH: Electroencephalographic activity and plasma ACTH during ethanol-induced euphoria. Biol Psychiatry 1988; 23:141-148
51. Read MR, Penick EC, Powell BJ, Nickel EJ, Bingham SF, Campbell J: Subtyping male alcoholics by family history of alcohol abuse and co-occurring psychiatric disorder: a bi-dimensional model. Br J Addict 1990; 85:367-378
52. Fils-Aime ML, Eckardt MJ, George DT, Brown GL, Mefford I, Linnoila M: Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindoleacetic acid levels than late-onset alcoholics. Arch Gen Psychiatry 1996; 53:211-216